Head-To-Head Contrast: Inspire Medical Systems (NYSE:INSP) & Nyxoah (NASDAQ:NYXH)

Inspire Medical Systems (NYSE:INSP) and Nyxoah (NASDAQ:NYXH) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Profitability

This table compares Inspire Medical Systems and Nyxoah’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	6.67%	8.19%	7.09%
Nyxoah	-1,043.93%	-51.68%	-40.11%

Volatility & Risk

Inspire Medical Systems has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.56, suggesting that its share price is 56% more volatile than the S&P 500.

Institutional & Insider Ownership

94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 17.1% of Nyxoah shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Inspire Medical Systems and Nyxoah, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	0	3	8	0	2.73
Nyxoah	0	0	4	0	3.00

Inspire Medical Systems currently has a consensus price target of $211.91, suggesting a potential upside of 47.94%. Nyxoah has a consensus price target of $14.50, suggesting a potential upside of 87.34%. Given Nyxoah’s stronger consensus rating and higher probable upside, analysts plainly believe Nyxoah is more favorable than Inspire Medical Systems.

Earnings and Valuation

This table compares Inspire Medical Systems and Nyxoah”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$840.11 million	5.03	$53.51 million	$2.17	66.01
Nyxoah	$4.36 million	60.41	-$46.77 million	($2.13)	-3.63

Inspire Medical Systems has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Summary

Inspire Medical Systems beats Nyxoah on 9 of the 14 factors compared between the two stocks.

About Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.